More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Visiox to Merge with Ocuvex to Advance Two Ophthalmic Drug Candidates
Author: Jennie Crabbe
Visiox Pharmaceuticals announced Aug. 19 that it had agreed to merge with Ocuvex Therapeutics, a privately held company in New Hyde Park, New York. A Visiox news release said Ocuvex has a pipeline of “near term” ophthalmic medicines, but gave no further details. No financial details were disclosed. The merged company will operate under the Ocuvex name, Visiox said. Visiox, of Columbus, Ohio, markets Omlonti (omidenepag isopropyl ophthalmic solution), an EP2 receptor agonist for ocular hyperte...
